Notably, iCAFs marked by TPM2 were enriched in the initial differentiation phase while myCAFs characterized by BIRC3, CCT6A, HNRNPF, and ID1 were enriched in the terminal differentiation phase during tumor progression. This evidence concerns the gene TPM2 and neoplasm.